The impact of imperfect screening tools on measuring the prevalence of epilepsy and headaches in Burkina Faso.
BACKGROUND:Epilepsy and progressively worsening severe chronic headaches (WSCH) are the two most common clinical manifestations of neurocysticercosis, a form of cysticercosis. Most community-based studies in sub-Saharan Africa (SSA) use a two-step approach (questionnaire and confirmation) to estimat...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2019-01-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | http://europepmc.org/articles/PMC6353216?pdf=render |
| _version_ | 1828163288486117376 |
|---|---|
| author | Ida Sahlu Cici Bauer Rasmané Ganaba Pierre-Marie Preux Linda D Cowan Pierre Dorny Athanase Millogo Hélène Carabin |
| author_facet | Ida Sahlu Cici Bauer Rasmané Ganaba Pierre-Marie Preux Linda D Cowan Pierre Dorny Athanase Millogo Hélène Carabin |
| author_sort | Ida Sahlu |
| collection | DOAJ |
| description | BACKGROUND:Epilepsy and progressively worsening severe chronic headaches (WSCH) are the two most common clinical manifestations of neurocysticercosis, a form of cysticercosis. Most community-based studies in sub-Saharan Africa (SSA) use a two-step approach (questionnaire and confirmation) to estimate the prevalence of these neurological disorders and neurocysticercosis. Few validate the questionnaire in the field or account for the imperfect nature of the screening questionnaire and the fact that only those who screen positive have the opportunity to be confirmed. This study aims to obtain community-based validity estimates of a screening questionnaire, and to assess the impact of verification bias and misclassification error on prevalence estimates of epilepsy and WSCH. METHODOLOGY/PRINCIPAL FINDINGS:Baseline screening questionnaire followed by neurological examination data from a cluster randomized controlled trial collected between February 2011 and January 2012 were used. Bayesian latent-class models were applied to obtain verification bias adjusted validity estimates for the screening questionnaire. These models were also used to compare the adjusted prevalence estimates of epilepsy and WSCH to those directly obtained from the data (i.e. unadjusted prevalence estimates). Different priors were used and their corresponding posterior inference was compared for both WSCH and epilepsy. Screening data were available for 4768 individuals. For epilepsy, posterior estimates for the sensitivity varied with the priors used but remained robust for the specificity, with the highest estimates at 66.1% (95%BCI: 56.4%;75.3%) for sensitivity and 88.9% (88.0%;89.8%) for specificity. For WSCH, the sensitivity and specificity estimates remained robust, with the highest at 59.6% (49.7%;69.1%) and 88.6% (87.6%;89.6%), respectively. The unadjusted prevalence estimates were consistently lower than the adjusted prevalence estimates for both epilepsy and WSCH. CONCLUSIONS/SIGNIFICANCE:This study demonstrates that in some settings, the prevalence of epilepsy and WSCH can be considerably underestimated when using the two-step approach. We provide an analytic solution to obtain more valid prevalence estimates of these neurological disorders, although more community-based validity studies are needed to reduce the uncertainty of the estimates. Valid estimates of these two neurological disorders are essential to obtain accurate burden values for neglected tropical diseases such as neurocysticercosis that manifest as epilepsy or WSCH. TRIAL REGISTRATION:ClinicalTrials.gov NCT03095339. |
| first_indexed | 2024-04-12T01:07:53Z |
| format | Article |
| id | doaj.art-7227472185be401c94f3b87d1682b8c7 |
| institution | Directory Open Access Journal |
| issn | 1935-2727 1935-2735 |
| language | English |
| last_indexed | 2024-04-12T01:07:53Z |
| publishDate | 2019-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Neglected Tropical Diseases |
| spelling | doaj.art-7227472185be401c94f3b87d1682b8c72022-12-22T03:54:12ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352019-01-01131e000710910.1371/journal.pntd.0007109The impact of imperfect screening tools on measuring the prevalence of epilepsy and headaches in Burkina Faso.Ida SahluCici BauerRasmané GanabaPierre-Marie PreuxLinda D CowanPierre DornyAthanase MillogoHélène CarabinBACKGROUND:Epilepsy and progressively worsening severe chronic headaches (WSCH) are the two most common clinical manifestations of neurocysticercosis, a form of cysticercosis. Most community-based studies in sub-Saharan Africa (SSA) use a two-step approach (questionnaire and confirmation) to estimate the prevalence of these neurological disorders and neurocysticercosis. Few validate the questionnaire in the field or account for the imperfect nature of the screening questionnaire and the fact that only those who screen positive have the opportunity to be confirmed. This study aims to obtain community-based validity estimates of a screening questionnaire, and to assess the impact of verification bias and misclassification error on prevalence estimates of epilepsy and WSCH. METHODOLOGY/PRINCIPAL FINDINGS:Baseline screening questionnaire followed by neurological examination data from a cluster randomized controlled trial collected between February 2011 and January 2012 were used. Bayesian latent-class models were applied to obtain verification bias adjusted validity estimates for the screening questionnaire. These models were also used to compare the adjusted prevalence estimates of epilepsy and WSCH to those directly obtained from the data (i.e. unadjusted prevalence estimates). Different priors were used and their corresponding posterior inference was compared for both WSCH and epilepsy. Screening data were available for 4768 individuals. For epilepsy, posterior estimates for the sensitivity varied with the priors used but remained robust for the specificity, with the highest estimates at 66.1% (95%BCI: 56.4%;75.3%) for sensitivity and 88.9% (88.0%;89.8%) for specificity. For WSCH, the sensitivity and specificity estimates remained robust, with the highest at 59.6% (49.7%;69.1%) and 88.6% (87.6%;89.6%), respectively. The unadjusted prevalence estimates were consistently lower than the adjusted prevalence estimates for both epilepsy and WSCH. CONCLUSIONS/SIGNIFICANCE:This study demonstrates that in some settings, the prevalence of epilepsy and WSCH can be considerably underestimated when using the two-step approach. We provide an analytic solution to obtain more valid prevalence estimates of these neurological disorders, although more community-based validity studies are needed to reduce the uncertainty of the estimates. Valid estimates of these two neurological disorders are essential to obtain accurate burden values for neglected tropical diseases such as neurocysticercosis that manifest as epilepsy or WSCH. TRIAL REGISTRATION:ClinicalTrials.gov NCT03095339.http://europepmc.org/articles/PMC6353216?pdf=render |
| spellingShingle | Ida Sahlu Cici Bauer Rasmané Ganaba Pierre-Marie Preux Linda D Cowan Pierre Dorny Athanase Millogo Hélène Carabin The impact of imperfect screening tools on measuring the prevalence of epilepsy and headaches in Burkina Faso. PLoS Neglected Tropical Diseases |
| title | The impact of imperfect screening tools on measuring the prevalence of epilepsy and headaches in Burkina Faso. |
| title_full | The impact of imperfect screening tools on measuring the prevalence of epilepsy and headaches in Burkina Faso. |
| title_fullStr | The impact of imperfect screening tools on measuring the prevalence of epilepsy and headaches in Burkina Faso. |
| title_full_unstemmed | The impact of imperfect screening tools on measuring the prevalence of epilepsy and headaches in Burkina Faso. |
| title_short | The impact of imperfect screening tools on measuring the prevalence of epilepsy and headaches in Burkina Faso. |
| title_sort | impact of imperfect screening tools on measuring the prevalence of epilepsy and headaches in burkina faso |
| url | http://europepmc.org/articles/PMC6353216?pdf=render |
| work_keys_str_mv | AT idasahlu theimpactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso AT cicibauer theimpactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso AT rasmaneganaba theimpactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso AT pierremariepreux theimpactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso AT lindadcowan theimpactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso AT pierredorny theimpactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso AT athanasemillogo theimpactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso AT helenecarabin theimpactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso AT idasahlu impactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso AT cicibauer impactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso AT rasmaneganaba impactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso AT pierremariepreux impactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso AT lindadcowan impactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso AT pierredorny impactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso AT athanasemillogo impactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso AT helenecarabin impactofimperfectscreeningtoolsonmeasuringtheprevalenceofepilepsyandheadachesinburkinafaso |